Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Dan Calvo, Erik Wallden

Premium

Gyros has appointed Dan Calvo to serve as president and CEO. He replaces Erik Walldén, who had served in the same roles since 2009.

Calvo previously served as president and CEO of Oncoimmune USA. He held the same positions at Assay Designs and Cellomics. Oncoimmune USA, Assay Designs, and Cellomics have since been acquired by Health Discovery Lab, Enzo Biochem, and Thermo Fisher, respectively.

Uppsala, Sweden-based Gyros sells a microfluidics-based platform for performing immunoassays.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.